Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Boisnard, F."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Boisnard F; Global Medical, Sanofi, Lyon, France., Manson C; Patient Safety & Pharmacovigilance, Sanofi, Lyon, France., Serradell L; Epidemiology and Benefit-Risk Department, Sanofi, Lyon, France., Macina D; Global Medical, Sanofi, Lyon, France.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2023 Jan-Dec; Vol. 22 (1), pp. 1196-1213. Date of Electronic Publication: 2023 Dec 06.
Publikováno v:
In Vaccine 2006 24(20):4450-4457
Autor:
Baïssas T; CVA, London, UK., Boisnard F; Sanofi Pasteur, 14, Espace Henry Vallée, 69007, Lyon, France., Cuesta Esteve I; Asociación Nacional de Enfermería y Vacunas, Zaragoza, Spain., Garcia Sánchez M; Hospital Quirónsalud Málaga, Málaga, Spain., Jones CE; Faculty of Medicine and Institute for Life Sciences University of Southampton and NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Rigoine de Fougerolles T; CVA, Paris, France., Tan L; Immunisation Action Coalition, Saint Paul, MN, USA., Vitoux O; CVA, Paris, France., Klein C; Sanofi Pasteur, 14, Espace Henry Vallée, 69007, Lyon, France. christina.klein@sanofi.com.
Publikováno v:
BMC public health [BMC Public Health] 2021 Nov 29; Vol. 21 (1), pp. 2182. Date of Electronic Publication: 2021 Nov 29.
Autor:
Oliver JL; Bristol Children's Vaccine Centre, University of Bristol & University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Sadorge C; Sanofi Pasteur MSD, Lyon, France., Boisnard F; Sanofi Pasteur MSD, Lyon, France., Snape MD; Oxford Vaccine Group, University of Oxford Department of Paediatrics and the NIHR Oxford Biomedical Research Council, Oxford, UK., Tomlinson R; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Mann R; Taunton and Somerset NHS Foundation Trust, Somerset, UK., Rudd P; Royal Hospitals Bath NHS Foundation Trust, Bath, UK., Bhakthavalsala S; Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK., Faust SN; NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK., Heath PT; St George's, University of London and St George's University Hospitals NHS Foundation Trust, London, UK., Hughes SM; Manchester University NHS Foundation Trust, Manchester, UK., Borrow R; Public Health England, Manchester Royal Infirmary, Manchester, UK., Thomas S; Sanofi Pasteur MSD, Lyon, France., Finn A; Bristol Children's Vaccine Centre, University of Bristol & University Hospitals Bristol NHS Foundation Trust, Bristol, UK. Electronic address: Adam.Finn@bristol.ac.uk.
Publikováno v:
Vaccine [Vaccine] 2020 Jul 31; Vol. 38 (35), pp. 5718-5725. Date of Electronic Publication: 2020 Jul 10.
Autor:
Vesikari T; Vaccine Research Center, FM3/Biokatu 10, 33014 University of Tampere, Tampere, Finland. Electronic address: timo.vesikari@uta.fi., Borrow R; Vaccine Evaluation Unit, Public Health England, Clinical Sciences Building 2, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK. Electronic address: ray.borrow@phe.gov.uk., Da Costa X; Sanofi Pasteur Inc., Global Clinical Immunology, PO Box 187, Discovery Drive, Swiftwater, PA 18370-0190, USA. Electronic address: xdacosta@hotmail.com)., Thomas S; Sanofi Pasteur MSD, 162 Avenue Jean Jaures, 69367 Lyon Cedex 07, France. Electronic address: Stephane.thomas10@free.fr., Eymin C; Sanofi Pasteur MSD, 162 Avenue Jean Jaures, 69367 Lyon Cedex 07, France. Electronic address: cecile.eymin@sanofi.com., Boisnard F; Sanofi Pasteur MSD, 162 Avenue Jean Jaures, 69367 Lyon Cedex 07, France. Electronic address: florence.boisnard@sanofi.com., Lockhart S; Sanofi Pasteur MSD, 162 Avenue Jean Jaures, 69367 Lyon Cedex 07, France. Electronic address: Stephen.lockhart@pfizer.com.
Publikováno v:
Vaccine [Vaccine] 2018 Dec 18; Vol. 36 (52), pp. 8019-8027. Date of Electronic Publication: 2018 Nov 22.
Autor:
Martinón-Torres F; Translational Pediatrics and Infectious Diseases, Department of Pediatrics, Hospital Clinico Universitario de Santiago de Compostela, c/ A Choupana s.n., 15706 Santiago de Compostela, Spain. Electronic address: federico.martinon.torres@sergas.es., Boisnard F; Sanofi Pasteur MSD, 162 Avenue Jean Jaurès, CS 50712, 69367 Lyon Cedex 07, France. Electronic address: boisnard.flo@gmail.com., Thomas S; Sanofi Pasteur MSD, 162 Avenue Jean Jaurès, CS 50712, 69367 Lyon Cedex 07, France. Electronic address: sthomas@spmsd.com., Sadorge C; Sanofi Pasteur MSD, 162 Avenue Jean Jaurès, CS 50712, 69367 Lyon Cedex 07, France. Electronic address: csadorge2002@yahoo.fr., Borrow R; Manchester Medical Microbiology Partnership, Public Health England, PO Box 209, Clinical Sciences Building, Manchester Royal Infirmary, Manchester M13 9WZ, UK. Electronic address: ray.borrow@phe.gov.uk.
Publikováno v:
Vaccine [Vaccine] 2017 Jun 27; Vol. 35 (30), pp. 3764-3772. Date of Electronic Publication: 2017 Jun 02.
Autor:
Lee AW; a Merck & Co., Inc. , Kenilworth , NJ , USA., Jordanov E; b Sanofi Pasteur , Swiftwater , PA , USA., Boisnard F; c Sanofi Pasteur MSD , Lyon , France., Marshall GS; d University of Louisville , Louisville , KY , USA.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2017 Feb; Vol. 16 (2), pp. 85-92. Date of Electronic Publication: 2016 Dec 20.
Autor:
Vesikari T; From the *Department of Pediatrics, University of Tampere, Tampere, Finland; †Clinical Practice, Alsfeld, Germany; ‡Sint-Vincentius GZA, Antwerp, Belgium; §Merck & Co., Inc., Kenilworth, NJ; and ¶Sanofi Pasteur MSD, Lyon, France., Becker T, Vertruyen AF, Poschet K, Flores SA, Pagnoni MF, Xu J, Liu GF, Stek JE, Boisnard F, Thomas S, Ziani E, Lee AW
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2017 Feb; Vol. 36 (2), pp. 209-215.
Autor:
Vesikari T; Vaccine Research Center, FM3/Biokatu 10, 33014 University of Tampere, Tampere, Finland. Electronic address: timo.vesikari@uta.fi., Borrow R; Vaccine Evaluation Unit, Public Health England, Clinical Sciences Building 2, Manchester Royal Infirmary, Manchester, UK. Electronic address: ray.borrow@phe.gov.uk., Da Costa X; Sanofi Pasteur Inc., Global Clinical Immunology, Discovery Drive, Swiftwater, PA, USA. Electronic address: xavier.dacosta@sanofipasteur.com., Richard P; Sanofi Pasteur MSD, 162 avenue Jean Jaures, CS 50712, 69367 Lyon Cedex 07, France. Electronic address: pr.richard@laposte.net., Eymin C; Sanofi Pasteur MSD, 162 avenue Jean Jaures, CS 50712, 69367 Lyon Cedex 07, France. Electronic address: cecile.eymin@neuf.fr., Boisnard F; Sanofi Pasteur MSD, 162 avenue Jean Jaures, CS 50712, 69367 Lyon Cedex 07, France. Electronic address: fboisnard@spmsd.com., Lockhart S; Sanofi Pasteur MSD, 162 avenue Jean Jaures, CS 50712, 69367 Lyon Cedex 07, France. Electronic address: slockhart@spmsd.com.
Publikováno v:
Vaccine [Vaccine] 2017 Jan 11; Vol. 35 (3), pp. 452-458. Date of Electronic Publication: 2016 Dec 09.